Why greedy banks are hiding the “29% Account”

179 patents. Billion-dollar pharma deals. Shares under $5.

Dear Reader, Once or twice a century, medicine makes a leap that changes everything. Penicillin. The polio vaccine. Antibiotics. I believe we're witnessing the next one. After 140 years of failure, a team of maverick scientists outside Boston just used AI to crack nature’s forbidden code. You have the rare opportunity to get in on the ground floor. This tiny company has a 179 strong patent fortress protecting its breakthrough. Four pharma giants are already paying billions for access. BlackRock, Vanguard, and State Street have quietly accumulated over 10 million shares. Goldman Sachs is calling this "a seismic shift." Its stock still trades under $5. See the full story here. Six months from now, you'll be glad you did. Adam O'Dell Chief Investment Strategist, All-Time Higher Summit (c) 2026 Money & Markets. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement. Any reproduction, copying, or redistribution, (electronic or otherwise) in whole or in part, is strictly prohibited without the express written permission of Money & Markets. 702 Cathedral Street, Baltimore, MD 21201. (TEL: 800-684-8471) Legal Notice The mailbox associated with this email address is not monitored, so please do not reply. However, your feedback is very important to us so if you would like to contact us, please click here. Remove your email from this list: Click here to Unsubscribe Reference number: 000122325764